Cognitive behavioural therapies versus treatment as usual for depression.
Vivien Hunot, Theresa Hm Moore, Deborah Caldwell, Philippa Davies, Hannah Jones, Toshi A Furukawa, Glyn Lewis, Rachel Churchill
Author Information
Vivien Hunot: Academic Unit of Psychiatry, School of Social and Community Medicine, University of Bristol, Bristol, UK.
Theresa Hm Moore: Academic Unit of Psychiatry, School of Social and Community Medicine, University of Bristol, Bristol, UK.
Deborah Caldwell: School of Social and Community Medicine, University of Bristol, Bristol, UK.
Philippa Davies: Academic Unit of Psychiatry, School of Social and Community Medicine, University of Bristol, Bristol, UK.
Hannah Jones: Cochrane Schizophrenia Group, The University of Nottingham, Nottingham, UK.
Toshi A Furukawa: Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.
Glyn Lewis: School of Social and Community Medicine, University of Bristol, Bristol, UK.
Rachel Churchill: Academic Unit of Psychiatry, School of Social and Community Medicine, University of Bristol, Bristol, UK.
This is the protocol for a review and there is no abstract. The objectives are as follows: To examine the effectiveness and acceptability of all cognitive behavioural therapies compared with treatment as usual/waiting list/attention placebo control conditions for acute depression.To examine the effectiveness and acceptability of different cognitive behavioural therapy models (cognitive therapy, rational emotive behaviour therapy, problem-solving therapy, self-control therapy and the Coping with Depression course) compared with treatment as usual/waiting list/attention placebo control conditions for acute depression.To examine the effectiveness and acceptability of all cognitive behavioural therapies compared with different types of comparator (standard care, no treatment, waiting list, attention placebo) for acute depression.
